Rocket Lab (RKLB) successfully launched its 98th Electron mission, carrying satellites for signals intelligence company HawkEye 360 from New Zealand.The mission delivered three HAWK satellites to a 520km low Earth orbit. It was Rocket Lab’s third dedicated Electron launch for HawkEye 360 and its 19th successful mission in 2026.

Decipher predicts benefit from adding abiraterone to ADT in very high‑risk nonmetastatic prostate cancer; Phase III STAMPEDE analysis.

Summary generation in progress for PHAT news. Please check back later.

Phase1b: brezosiran (ALN-HTT02) mHTT ↓60–64% mean at month3 (up to 83%); encouraging safety; potential twice‑yearly dosing.

ORIC Pharmaceuticals (ORIC) reported enozertinib Phase 1b lung cancer results and plans to advance the drug into a global Phase 3 trial. Among previously untreated patients with EGFR atypical mutations, confirmed systemic objective response rates (tumor shrinkage) were 84% by investigators and 80% by blinded independent review. The September 4, 2026 dataset included 26 patients; 65% had baseline brain metastases.Intracranial response rates were 70% by investigators and 67% under independent…

ORIC Pharmaceuticals (ORIC) presented preclinical and patient-sample data at ESMO Congress 2026 supporting rinzimetostat’s potential to enhance androgen receptor inhibition in prostate cancer. In preclinical studies, rinzimetostat maintained potency against an EZH2 mutation associated with resistance to mevrometostat; no rinzimetostat-resistant cells emerged. No hematologic tumorigenesis was observed in its rat toxicology study, versus tumorigenesis demonstrated with tazemetostat.Rinzimetostat…

IQM Quantum Computers (Nasdaq: IQMX) and Telefónica will deploy the Community of Madrid’s first quantum computer at Universidad Politécnica de Madrid.The IQM Spark system is scheduled for installation before the end of 2026. Universities, hospitals, research centers and start-ups will have direct access to the hardware to develop and test quantum algorithms. IQM expects the project to support researchers, students and industry in building quantum capabilities and exploring future applications.

89% vaccine target precision; all patients immune response; no tumor progression through 3-year follow-up.

Zai Lab (NASDAQ: ZLAB; HKEX: 9688) signed a securities purchase agreement for a private placement expected to raise approximately $250 million. The financing involves 11,340,000 American Depositary Shares (ADSs) at $22.04 each, with each ADS representing ten ordinary shares. Expected gross proceeds exclude placement agent fees and other offering expenses.TCGX leads the financing, which includes new and existing investors. Zai Lab expects closing on or about October 27, 2026, subject to…

Sensata Technologies (NYSE: ST) approved a quarterly dividend of $0.12 per share, payable on November 25, 2026. The fourth-quarter 2026 dividend will be paid to shareholders of record as of November 11, 2026, following approval by the Board of Directors.